A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

This study is currently recruiting participants.
Verified January 2014 by Therapeutic Advances in Childhood Leukemia Consortium
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium
ClinicalTrials.gov Identifier:
NCT01321346
First received: March 21, 2011
Last updated: January 31, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)